Authors/Disclosures
|
Robyn Honea, PhD
|
No disclosure on file |
|
|
No disclosure on file |
|
Eric Vidoni, PhD, PT
(ALZHEIMER & MEMORY PROGRAM)
|
No disclosure on file |
|
Sara K. Rostanski, MD
(NYU School of Medicine)
|
Dr. Rostanski has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for individual law firms. |
|
|
No disclosure on file |
|
Russell H. Swerdlow, MD
|
No disclosure on file |
|
Andrew J. Saykin, PsyD
(Indiana University School of Medicine)
|
Dr. Saykin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer Oncology. Dr. Saykin has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature Publishing. The institution of Dr. Saykin has received research support from Eli Lilly/Avid Radiopharmaceuticals. |
|
Laura Jardim
|
No disclosure on file |
|
Alison Goate, PhD
(WA Univ Sch of Medicine)
|
No disclosure on file |
|
Jeffrey M. Burns, MD
(University of Kansas)
|
Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Renew Research. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Norris, Keplinger, Hicks and Welder. The institution of Dr. Burns has received research support from National Institutes of Health. The institution of Dr. Burns has received research support from Biogen. The institution of Dr. Burns has received research support from Eli Lilly. The institution of Dr. Burns has received research support from Amylyx. The institution of Dr. Burns has received research support from Abbvie. The institution of Dr. Burns has received research support from Astra-Zeneca. |